SGO 2022 Conference Coverage on VuMedi
Video Player is loading.
10 seconds
Playback speed
SGO 2022 on a Phase 2 OVARIO Study of Niraparib + Bevacizumab in Advanced Ovarian Cancer Following Frontline PBC With Bevacizumab
By
SGO 2022 Conference Coverage on VuMedi
FEATURING
Melissa Hardesty
By
SGO 2022 Conference Coverage on VuMedi
FEATURING
Melissa Hardesty
Comments 0
Login to view comments.
Click here to Login
